Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ParaTechs is a biotechnology company specializing in advanced protein expression systems and insect cell line technologies. The company's flagship platform, VE-PEx (Virus-Enhanced Protein Expression), utilizes a unique baculovirus-based system to achieve high-yield, cost-effective production of complex recombinant proteins. ParaTechs provides a range of products including specialized cell lines, expression vectors, and custom protein production services to support academic and industrial research. Based in Lexington, Kentucky, the company leverages proprietary technology originally developed at the University of Kentucky to address challenges in protein folding and post-translational modifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ParaTech A.